Medical Subject Headings

Last uploaded: March 22, 2026

Id	http://purl.bioontology.org/ontology/MESH/C519271 http://purl.bioontology.org/ontology/MESH/C519271
Preferred Name	bivatuzumab mertansine
Synonyms	BIWI 1 compound
Type	http://www.w3.org/2002/07/owl#Class

altLabel	BIWI 1 compound
prefLabel	bivatuzumab mertansine
Scope Statement	CD44v6-targeting humanized monoclonal antibody coupled to the toxin mertansine for treatment of squamous cell carcinoma of the head and neck
type	http://www.w3.org/2002/07/owl#Class
isa	http://purl.bioontology.org/ontology/MESH/D000972 http://purl.bioontology.org/ontology/MESH/D000922 http://purl.bioontology.org/ontology/MESH/D000074322
PA	D000074322 D000972 D000922
tui	T129
Has mapping qualifier	http://purl.bioontology.org/ontology/MESH/Q000031
HM	D008453/Q000031 D061067
SC	1
TERMUI	T696596 T696597
TH	NLM (2007)
SRC	Int J Oncol 2007 Apr;30(4):927-35
MMR	20170922
notation	C519271
Semantic type UMLS property	http://purl.bioontology.org/ontology/STY/T129
cui	C1956540
MeSH Frequency	3
PI	*ANTIGBODIES, MONOCLONAL (2007-2011)
DSC	20070502
Inverse of RB	0
Mapped to	http://purl.bioontology.org/ontology/MESH/D008453 http://purl.bioontology.org/ontology/MESH/D061067
MDA	20070502

Delete	Subject	Author	Type	Created
No notes to display